Mitsuko Furuya Selected Research

Humanized Monoclonal Antibodies

1/2011

Complexity of tumor vasculature and molecular targeting therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuko Furuya Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 01/2005
9	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 05/2004
7	Carcinoma (Carcinomatosis) 12/2021 - 04/2005
6	Cysts 01/2020 - 07/2002
5	Kidney Neoplasms (Kidney Cancer) 01/2019 - 03/2015
5	Neoplasm Metastasis (Metastasis) 11/2016 - 12/2006
4	Birt-Hogg-Dube Syndrome 03/2016 - 10/2013
4	Adenocarcinoma 01/2016 - 01/2005
3	Endometriosis 09/2011 - 01/2002
2	Hereditary leiomyomatosis and renal cell cancer 01/2021 - 12/2020
2	Carcinogenesis 01/2020 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 07/2016 - 06/2007
2	Hypoxia (Hypoxemia) 04/2015 - 01/2013
2	Ovarian Neoplasms (Ovarian Cancer) 04/2015 - 09/2011
2	Tuberous Sclerosis (Bourneville's Disease) 10/2013 - 03/2012
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2010 - 11/2008
2	Neuroendocrine Carcinoma 04/2010 - 11/2008
2	Carcinoid Tumor (Carcinoid) 11/2006 - 01/2005
1	Medullary Carcinoma 01/2022
1	Abdominal Abscess 12/2021
1	Neoplasm Micrometastasis 12/2021
1	Hamartoma 03/2016
1	Starvation 04/2015
1	Polyps 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 07/2013
1	Liver Cell Adenoma (Hepatocellular Adenoma) 07/2013
1	Prostatic Neoplasms (Prostate Cancer) 11/2012
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 05/2012
1	Cystic Kidney Diseases (Cystic Kidney Disease) 03/2012
1	Gallstones (Gallstone) 01/2010
1	Gastro-enteropancreatic neuroendocrine tumor 11/2008
1	Circulating Neoplastic Cells 06/2008
1	Hypertension (High Blood Pressure) 04/2008
1	Pre-Eclampsia (Preeclampsia) 04/2008

Drug/Important Bio-Agent (IBA)

5	Fumarate Hydratase (Fumarase)IBA 01/2022 - 01/2018
5	Messenger RNA (mRNA)IBA 01/2018 - 01/2005
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2004
4	Transcription Factors (Transcription Factor)IBA 11/2021 - 06/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 06/2008
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 03/2015
3	Chemotactic FactorsIBA 01/2009 - 01/2005
3	ChemokinesIBA 11/2007 - 01/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2002
2	Microphthalmia-Associated Transcription FactorIBA 08/2019 - 03/2019
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 05/2014
2	Biological ProductsIBA 01/2014 - 11/2008
2	trans-sodium crocetinate (crocetin)IBA 10/2013 - 03/2012
2	Ribosomal Proteins (Ribosomal Protein)IBA 04/2012 - 03/2012
2	TOR Serine-Threonine KinasesIBA 04/2012 - 04/2010
2	CXC ChemokinesIBA 09/2011 - 11/2007
2	Tyrosine Kinase InhibitorsIBA 01/2009 - 06/2008
2	Monoclonal AntibodiesIBA 01/2009 - 06/2008
2	Bevacizumab (Avastin)FDA Link 01/2009 - 06/2008
2	Interferon-gamma (Interferon, gamma)IBA 11/2007 - 01/2005
2	Matrix Metalloproteinases (MMPs)IBA 09/2007 - 07/2002
2	IntegrinsIBA 09/2007 - 04/2005
2	Mitogen-Activated Protein Kinase 14IBA 01/2007 - 12/2006
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	NucleotidesIBA 01/2020
1	Cathepsin KIBA 03/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 07/2016
1	TubulinIBA 07/2016
1	S 1 (combination)IBA 07/2016
1	ElementsIBA 03/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	LipidsIBA 04/2015
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2015
1	Sp1 Transcription FactorIBA 04/2015
1	Estrogen ReceptorsIBA 01/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2014
1	Keratin-7 (Cytokeratin 7)IBA 01/2014
1	Keratins (Keratin)IBA 01/2014
1	Capsules (Microcapsules)IBA 01/2014
1	NFI Transcription FactorsIBA 07/2013
1	Biomarkers (Surrogate Marker)IBA 11/2012
1	MicroRNAs (MicroRNA)IBA 11/2012
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 05/2012
1	LigandsIBA 09/2011
1	Chemokine ReceptorsIBA 09/2011
1	Humanized Monoclonal AntibodiesIBA 01/2011
1	MTOR InhibitorsIBA 04/2010
1	Everolimus FDA Link 04/2010
1	Sunitinib (Sutent)FDA Link 01/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2009
1	Oxygen (Dioxygen)IBA 06/2008
1	ReninIBA 04/2008
1	AngiotensinogenIBA 04/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2007
1	Interleukin-8B ReceptorsIBA 11/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2007

Therapy/Procedure

12	Therapeutics 12/2021 - 01/2005
4	Nephrectomy 01/2022 - 01/2010
2	Hysterectomy 12/2021 - 11/2016
1	Drug Therapy (Chemotherapy) 12/2021
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 07/2016
1	Hepatectomy 07/2013
1	Cholecystectomy 01/2010